4577.Tライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (1 5月 2024 @ 15:15):

Stats
本日の出来高	81 900.00
平均出来高	61 533.00
時価総額	39.11B
EPS	¥0 ( 2024-04-12 )
次の収益日	( ¥0 ) 2024-07-11
Last Dividend	¥30.00 ( 2023-05-30 )
Next Dividend	¥0 ( N/A )
P/E	12.03
ATR14	¥1.285 (0.05%)

ボリューム相関

長: -0.08 (neutral)

短: 0.88 (strong)

Signal:(54.338) Same movement expected

Daito Pharmaceutical 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Daito Pharmaceutical 相関 - 通貨/商品

0.10
( neutral )

0.20
( neutral )

0.21
( neutral )

0.22
( neutral )

0.18
( neutral )

Daito Pharmaceutical 財務諸表

Annual	2022
収益:	¥45.10B
総利益:	¥10.33B (22.91 %)
EPS:	¥227.64

FY	2022
収益:	¥45.10B
総利益:	¥10.33B (22.91 %)
EPS:	¥227.64

FY	2022
収益:	¥43.46B
総利益:	¥11.46B (26.36 %)
EPS:	¥335.41

FY	2021
収益:	¥48.71B
総利益:	¥10.79B (22.16 %)
EPS:	¥311.02

Financial Reports:

No articles found.

Daito Pharmaceutical Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
¥0 (N/A)	¥30.00 (N/A)	¥0 (N/A)	¥30.00 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)

Daito Pharmaceutical Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 3.80 - Decrease likely (24.00%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	¥4.55	2010-05-27
Last Dividend	¥30.00	2023-05-30
Next Dividend	¥0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	24	--
Total Paid Out	¥396.45	--
Avg. Dividend % Per Year	0.00%	--
Score	3.49	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	3.80
Div. Directional Score	7.50	--

Next Divdend (Est)
(2024-07-08)

¥0 Estimate 3.54 %

Dividend Stability

0.28 Very Poor

Dividend Score

3.49

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for JPX

Symbol	Title	Last dividend	Frequency	Yearly Dividend
8125.T	Ex Dividend Knight	2024-02-28	Annually	0.00%
7463.T	Ex Dividend Junior	2023-09-28	Semi-Annually	0.00%
6678.T	Ex Dividend Junior	2024-03-28	Annually	0.00%
6023.T	Ex Dividend Knight	2024-03-28	Annually	0.00%
4716.T	Ex Dividend Junior	2023-05-30	Annually	0.00%
3946.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
3168.T	Ex Dividend Junior	2023-08-30	Semi-Annually	0.00%
2150.T	Ex Dividend Knight	2023-12-29	Annually	0.00%
9031.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
7917.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0726	1.500	8.55	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0424	1.200	8.59	10.00	[0 - 0.3]
returnOnEquityTTM	0.0639	1.500	-0.402	-0.602	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	2.29	0.800	3.53	2.82	[1 - 3]
quickRatioTTM	1.083	0.800	8.33	6.67	[0.8 - 2.5]
cashRatioTTM	0.202	1.500	9.99	10.00	[0.2 - 2]
debtRatioTTM	0.0944	-1.500	8.43	-10.00	[0 - 0.6]
interestCoverageTTM	182.83	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	346.01	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	346.01	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0.141	-1.500	9.44	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.214	1.000	9.77	9.77	[0.2 - 0.8]
operatingProfitMarginTTM	0.0930	1.000	-0.139	-0.139	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.744	1.000	6.98	6.98	[0.2 - 2]
assetTurnoverTTM	0.584	0.800	9.44	7.55	[0.5 - 2]
Total Score				11.20

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	12.00	1.000	8.89	0	[1 - 100]
returnOnEquityTTM	0.0639	2.50	-0.258	-0.602	[0.1 - 1.5]
freeCashFlowPerShareTTM	346.01	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	2.28	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	346.01	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.474	1.500	-6.49	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.120	1.000	9.50	0	[0.1 - 0.5]
Total Score				3.80

Daito Pharmaceutical

Daito Pharmaceutical Co.,Ltd. manufactures and sells pharmaceutical products worldwide. The company offers various active pharmaceutical ingredients and intermediates, prescription drugs, OTC drugs, and home-delivery medicines; formulations in various forms, such as tablets, capsules, troches, granules, and powders; and contract manufacturing services for formulations of medicinal products to pharmaceutical companies. It also sells health food products. The company was formerly known as Daito Corporation and changed its name to Daito Pharmaceutical Co.,Ltd. in 1992. Daito Pharmaceutical Co.,Ltd. was incorporated in 1942 and is headquartered in Toyama, Japan.